BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 25141771)

  • 1. Lower heart rate variability predicts increased level of C-reactive protein 4 years later in healthy, nonsmoking adults.
    Jarczok MN; Koenig J; Mauss D; Fischer JE; Thayer JF
    J Intern Med; 2014 Dec; 276(6):667-71. PubMed ID: 25141771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart rate variability is independently associated with C-reactive protein but not with Serum amyloid A. The Cardiovascular Risk in Young Finns Study.
    Haarala A; Kähönen M; Eklund C; Jylhävä J; Koskinen T; Taittonen L; Huupponen R; Lehtimäki T; Viikari J; Raitakari OT; Hurme M
    Eur J Clin Invest; 2011 Sep; 41(9):951-7. PubMed ID: 21323913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher levels of inflammation factors and greater insulin resistance are independently associated with higher heart rate and lower heart rate variability in normoglycemic older individuals: the Cardiovascular Health Study.
    Stein PK; Barzilay JI; Chaves PH; Traber J; Domitrovich PP; Heckbert SR; Gottdiener JS
    J Am Geriatr Soc; 2008 Feb; 56(2):315-21. PubMed ID: 18179502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of heart rate variability on C-reactive protein concentrations in Japanese adult nonsmokers: The Toon Health Study.
    Saito I; Hitsumoto S; Maruyama K; Eguchi E; Kato T; Okamoto A; Kawamura R; Takata Y; Nishida W; Nishimiya T; Onuma H; Osawa H; Tanigawa T
    Atherosclerosis; 2016 Jan; 244():79-85. PubMed ID: 26595902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High serum high-sensitivity C-reactive protein concentrations are associated with relative cardiac sympathetic overactivity during the early morning period in type 2 diabetic patients with metabolic syndrome.
    Aso Y; Wakabayashi S; Nakano T; Yamamoto R; Takebayashi K; Inukai T
    Metabolism; 2006 Aug; 55(8):1014-21. PubMed ID: 16839835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of heart rate variability to serum levels of C-reactive protein in patients with unstable angina pectoris.
    Lanza GA; Sgueglia GA; Cianflone D; Rebuzzi AG; Angeloni G; Sestito A; Infusino F; Crea F; Maseri A;
    Am J Cardiol; 2006 Jun; 97(12):1702-6. PubMed ID: 16765117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation is related to unbalanced cardiac autonomic functions in hypertension: an observational study.
    Celik A; Koç F; Kadi H; Ceyhan K; Erkorkmaz U
    Anadolu Kardiyol Derg; 2012 May; 12(3):233-40. PubMed ID: 22381923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein modulates vagal heart rate control in patients with coronary artery disease.
    Nolan RP; Reid GJ; Seidelin PH; Lau HK
    Clin Sci (Lond); 2007 Apr; 112(8):449-56. PubMed ID: 17134377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart rate variability, overnight urinary norepinephrine and C-reactive protein: evidence for the cholinergic anti-inflammatory pathway in healthy human adults.
    Thayer JF; Fischer JE
    J Intern Med; 2009 Apr; 265(4):439-47. PubMed ID: 19019182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High levels of C-reactive protein are associated with reduced vagal modulation and low physical activity in young adults.
    Soares-Miranda L; Negrao CE; Antunes-Correa LM; Nobre TS; Silva P; Santos R; Vale S; Mota J
    Scand J Med Sci Sports; 2012 Apr; 22(2):278-84. PubMed ID: 20626701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vagal nerve stimulation on systemic inflammation and cardiac autonomic function in patients with refractory epilepsy.
    Barone L; Colicchio G; Policicchio D; Di Clemente F; Di Monaco A; Meglio M; Lanza GA; Crea F
    Neuroimmunomodulation; 2007; 14(6):331-6. PubMed ID: 18418007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumogastric (Vagus) Nerve Activity Indexed by Heart Rate Variability in Chronic Pain Patients Compared to Healthy Controls: A Systematic Review and Meta-Analysis.
    Koenig J; Falvay D; Clamor A; Wagner J; Jarczok MN; Ellis RJ; Weber C; Thayer JF
    Pain Physician; 2016 Jan; 19(1):E55-78. PubMed ID: 26752494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-specific associations between cardiac vagal activity and functional somatic symptoms: a population-based study.
    Tak LM; Janssens KA; Dietrich A; Slaets JP; Rosmalen JG
    Psychother Psychosom; 2010; 79(3):179-87. PubMed ID: 20234148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationships among heart rate variability, inflammatory markers and depression in coronary heart disease patients.
    Frasure-Smith N; Lespérance F; Irwin MR; Talajic M; Pollock BG
    Brain Behav Immun; 2009 Nov; 23(8):1140-7. PubMed ID: 19635552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein, heart rate variability and prognosis in community subjects with no apparent heart disease.
    Sajadieh A; Nielsen OW; Rasmussen V; Hein HO; Hansen JF
    J Intern Med; 2006 Oct; 260(4):377-87. PubMed ID: 16961675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic relevance of the interaction between short-term, metronome-paced heart rate variability, and inflammation: results from the population-based CARLA cohort study.
    Medenwald D; Swenne CA; Loppnow H; Kors JA; Pietzner D; Tiller D; Thiery J; Nuding S; Greiser KH; Haerting J; Werdan K; Kluttig A
    Europace; 2017 Jan; 19(1):110-118. PubMed ID: 27221352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk.
    Onat A; Can G; Hergenç G
    Metabolism; 2008 Feb; 57(2):207-14. PubMed ID: 18191050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of, and factors associated with, C-reactive protein in employees attending a company-sponsored cardiac screening program.
    Godefroi R; Klementowicz P; Pepler C; Lewis B; McDonough K; Goldberg RJ
    Cardiology; 2005; 103(4):180-4. PubMed ID: 15785026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart rate variability is associated with glycemic status after controlling for components of the metabolic syndrome.
    Jarczok MN; Li J; Mauss D; Fischer JE; Thayer JF
    Int J Cardiol; 2013 Aug; 167(3):855-61. PubMed ID: 22386703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation and future risk of symptomatic heart failure in patients with stable coronary artery disease.
    Eisen A; Benderly M; Behar S; Goldbourt U; Haim M
    Am Heart J; 2014 May; 167(5):707-14. PubMed ID: 24766981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.